Back to Journals » Drug Design, Development and Therapy » Volume 11

A first-in-human, double-blind, placebo-controlled, randomized, dose escalation study of DWP05195, a novel TRPV1 antagonist, in healthy volunteers

Total article views   HTML views PDF downloads Totals
12,628 Dovepress* 11,879+ 1,376 13,255
PubMed Central* 749 236 985
Totals 12,628 1,612 14,240
*Since 24 April 2017
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar